115 related articles for article (PubMed ID: 12199540)
1. Glaucoma medical treatment--2002: does yearly cost now equal the year?
Doyle JW; Smith MF; Tierney JW
Optom Vis Sci; 2002 Aug; 79(8):489-92. PubMed ID: 12199540
[TBL] [Abstract][Full Text] [Related]
2. Medical therapy cost considerations for glaucoma.
Fiscella RG; Green A; Patuszynski DH; Wilensky J
Am J Ophthalmol; 2003 Jul; 136(1):18-25. PubMed ID: 12834665
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of glaucoma medications.
Rylander NR; Vold SD
Am J Ophthalmol; 2008 Jan; 145(1):106-13. PubMed ID: 18154755
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of glaucoma medications: a 3-year review.
Vold SD; Riggs WL; Jackimiec J
J Glaucoma; 2002 Aug; 11(4):354-8. PubMed ID: 12169974
[TBL] [Abstract][Full Text] [Related]
5. [Cost-effectivity analysis of the most used antiglaucoma drugs].
Galindo-Ferreiro A; Sánchez-Tocino H; Fernández-Muñoz M; Iglesias Cortiñas D
Arch Soc Esp Oftalmol; 2004 Aug; 79(8):379-84. PubMed ID: 15306964
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of glaucoma medications.
Fiscella RG; Jensen MK
Am J Ophthalmol; 2008 Jun; 145(6):1108-9; author reply 1109. PubMed ID: 18503789
[No Abstract] [Full Text] [Related]
7. Cost analysis of glaucoma medications.
Vold SD; Wiggins DA; Jackimiec J
J Glaucoma; 2000 Apr; 9(2):150-3. PubMed ID: 10782624
[TBL] [Abstract][Full Text] [Related]
8. Daily cost of glaucoma medications in China.
Gao Y; Wu L; Li A
J Glaucoma; 2007; 16(7):594-7. PubMed ID: 18091176
[TBL] [Abstract][Full Text] [Related]
9. A cost analysis of the prostaglandin analogs.
Mick AB; Gonzalez S; Dunbar MT; McSoley JJ
Optometry; 2002 Oct; 73(10):614-9. PubMed ID: 12408547
[TBL] [Abstract][Full Text] [Related]
10. Cost considerations of medical therapy for glaucoma.
Fiscella RG; Geller JL; Gryz LL; Wilensky J; Viana M
Am J Ophthalmol; 1999 Oct; 128(4):426-33. PubMed ID: 10577583
[TBL] [Abstract][Full Text] [Related]
11. Topical glaucoma therapy cost in Mexico.
Lazcano-Gomez G; Hernandez-Oteyza A; Iriarte-Barbosa MJ; Hernandez-Garciadiego C
Int Ophthalmol; 2014 Apr; 34(2):241-9. PubMed ID: 23846765
[TBL] [Abstract][Full Text] [Related]
12. Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care.
Fukuda Y; Kume A; Kashiwagi K
Curr Eye Res; 2021 Nov; 46(11):1695-1702. PubMed ID: 33843390
[No Abstract] [Full Text] [Related]
13. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand.
Ngan K; Fraser E; Buller S; Buller A
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2181-2189. PubMed ID: 30132278
[TBL] [Abstract][Full Text] [Related]
14. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
Goldberg LD; Walt J
Pharmacoeconomics; 2006; 24(3):251-64. PubMed ID: 16519547
[TBL] [Abstract][Full Text] [Related]
15. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
Queen JH; Feldman RM; Lee DA
Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
[TBL] [Abstract][Full Text] [Related]
16. Preferences for eye drop characteristics among glaucoma specialists: a willingness-to-pay analysis.
Jampel HD; Parekh P; Johnson E; Robin AL; Miller RB
J Glaucoma; 2005 Apr; 14(2):151-6. PubMed ID: 15741818
[TBL] [Abstract][Full Text] [Related]
17. Daily cost of ophthalmic solutions for treating glaucoma in Japan.
Ikeda H; Sato E; Kitaura T; Fukuchi H; Kimura Y; Kihira K
Jpn J Ophthalmol; 2001; 45(1):99-102. PubMed ID: 11163052
[TBL] [Abstract][Full Text] [Related]
18. Cost of selective laser trabeculoplasty vs topical medications for glaucoma.
Seider MI; Keenan JD; Han Y
Arch Ophthalmol; 2012 Apr; 130(4):529-30. PubMed ID: 22491929
[No Abstract] [Full Text] [Related]
19. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
Soto J
Pharmacoeconomics; 2006; 24(5):519-20; author reply 520-2. PubMed ID: 16706575
[No Abstract] [Full Text] [Related]
20. Patient preferences for eye drop characteristics: a willingness-to-pay analysis.
Jampel HD; Schwartz GF; Robin AL; Abrams DA; Johnson E; Miller RB
Arch Ophthalmol; 2003 Apr; 121(4):540-6. PubMed ID: 12695251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
